Antihemophilic factor/von Willebrand factor complex (Human, Grifols Biologicals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAntihemophilic factor/von Willebrand factor complex (Human, Grifols Biologicals)
Drug Alias Name抗血友病因子/血管性血友病因子 (Grifols Biologicals)凝血因子FVIII (Grifols Biologicals)抗血友病因子 (Grifols Biologicals)血管性血友病因子 (Grifols Biologicals)Alphanate
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsVon willebrand factor replacements +[4] 
TargetsCoagulation factor VIIICoagulation factor X
Therapy Area/Indicationsvon Willebrand DiseasesHemophilia A
Global Approved Indicationsvon Willebrand DiseasesHemophilia A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1978/08/15
Country/TerritoryCanadaUnited StatesRussian Federation +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGrifols Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrifols Therapeutics LlcGrifols Biologicals Llc
Active Indicationsvon Willebrand DiseasesHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD06
Related LinksWikipediaKEGG